Medios (OTCPK:MEDO.F) - Stock Price, News & Analysis

MEDO.F Stock Overview

Supplies specialty pharmaceutical drugs primarily in Germany. More details

MEDO.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 59.6% below our estimate of its fair value

Earnings are forecast to grow 34.03% per year

Risk Analysis

Shares are highly illiquid

Shareholders have been diluted in the past year

Medios AG Competitors

Patterson Companies

NasdaqGS:PDCO

US$1.8b

Henry Schein

NasdaqGS:HSIC

US$9.4b

DocGo

NasdaqCM:DCGO

US$433.7m

Viemed Healthcare

NasdaqCM:VMD

US$340.7m

Price History & Performance

Summary of all time highs, changes and price drops for Medios
Historical stock prices
Current Share Price	€13.64
52 Week High	€13.64
52 Week Low	€13.64
Beta	1.08
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-72.72%

Recent updates

Shareholder Returns

	MEDO.F	US Healthcare	US Market
7D	0%	1.6%	2.2%
1Y	n/a	2.1%	31.6%

Return vs Industry: Insufficient data to determine how MEDO.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how MEDO.F performed against the US Market.

Price Volatility

Is MEDO.F's price volatile compared to industry and market?
MEDO.F volatility
MEDO.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: MEDO.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MEDO.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	500	Matthias Gaertner	www.medios.ag

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.

Medios AG Fundamentals Summary

How do Medios's earnings and revenue compare to its market cap?
MEDO.F fundamental statistics
Market cap	US$488.08m
Earnings (TTM)	US$19.43m
Revenue (TTM)	US$1.96b

25.1x

P/E Ratio

0.2x

P/S Ratio

Is MEDO.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDO.F income statement (TTM)
Revenue	€1.81b
Cost of Revenue	€1.70b
Gross Profit	€107.44m
Other Expenses	€89.47m
Earnings	€17.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 13, 2024

Earnings per share (EPS)	0.70
Gross Margin	5.94%
Net Profit Margin	0.99%
Debt/Equity Ratio	0%

How did MEDO.F perform over the long term?

See historical performance and comparison

Medios OTCPK:MEDO.F Stock Report